glp-1 acronym 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often GLP-1 receptor agonists and next-generation

Not intended for use by persons under the age of 18 years

AAN: GLP-1 Receptor Agonist Initiation for Chronic Migraine Tied to Improved Outcomes MONDAY, March 2, 2026 -- For people with chronic migraine (CM), taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with fewer emergency department visits and hospitalizations overall and less need for medications used to stop and prevent migraine attacks, according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 18 to 22 in Chicago

See PepPal's stacking safety guide

While these medications are generally well-tolerated, knowing when effects typically appear and how long they persist can help you stay committed to your treatment plan and adjust expectations realistically